About Antex Pharma Private Limited
Data last updated:
Antex Pharma Private Limited is a private limited company based in Delhi, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 06 March 2009 and has been in existence for over 17 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U24100DL2009PTC188276. Its GSTIN is 06AAHCA8532F1ZS (Haryana). The company holds 2 GST registrations, of which 1 is active.
The company has an authorised share capital of ₹70 Lakh and a paid-up capital of ₹70 Lakh. It is led by directors Rajesh Kumar Hariharprasad Tiwari and Amardeep Bansal.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at 423 Main Bawana Road Shahbad Daulatpur, Delhi, India – 110042.
As per the financials filed for FY 2024, the company reported a revenue of ₹98.92 Cr, a growth of 23% compared to the previous year. For the same year it recorded a net profit of ₹62.06 Lakh (net margin 0.6%) and EBITDA of ₹1.12 Cr (EBITDA margin 1.1%). Revenue has grown at a compounded annual rate (CAGR) of 7% over three years and 1% over five years.
The company is associated with 1 brand: Antex Pharma. As per MCA filings, the company has open charges of ₹13.5 Cr and satisfied charges of ₹13.2 Cr on record. Court records list 223 cases involving the company, including 203 filed by the company and 18 filed against it; 116 cases are pending.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website antexpharma.com.
- EmailLocked
- TelephoneLocked
- Website
- Social Media
- Registered Address423 Main Bawana Road Shahbad Daulatpur, Delhi, India – 110042
- IndustryPharma, Pharmaceutical Retailers & Distributors
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Antex Pharma Private Limited
The main business activity of Antex Pharma is trade. In detail, this covers wholesale trading.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Antex Pharma Private Limited FY 2024 filings available
Antex Pharma Private Limited reported revenue of ₹98.92 Cr (up 23% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR) of Antex Pharma Private Limited
Revenue has grown at a compounded annual rate (CAGR) of 1% over five years, including 23% growth in the latest year. EBITDA fell 53% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Antex Pharma Private Limited
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹1.12 Cr | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹62.06 Lakh | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Antex Pharma Private Limited
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 1.1% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 0.6% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Antex Pharma are in the company report.
Financial statements from 2015
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of Antex Pharma Private Limited
Antex Pharma Private Limited is compared with the companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Amtrax (India) Life Sciences Private Limited | ₹100.75 Cr (FY 2025) | •••• | •••• | -8.0% | •••• | Mumbai, Maharashtra, India |
| Euro Lifecare Private Limited | ₹100.42 Cr (FY 2025) | •••• | •••• | -1.0% | •••• | Mumbai, Maharashtra, India |
| Arham Drugs and Chemicals Private Limited | ₹100.31 Cr (FY 2024) | •••• | •••• | 119.0% | •••• | Mumbai, Maharashtra, India |
| Jainam Pharma (India) Private Limited | ₹100.19 Cr (FY 2025) | •••• | •••• | -2.0% | •••• | Mumbai, Maharashtra, India |
| LPH Pharma Private Limited | ₹99.33 Cr (FY 2025) | •••• | •••• | 72.0% | •••• | Chennai, Tamil Nadu, India |
| Antex Pharma Private Limited this company | ₹98.92 Cr (FY 2024) | •••• | •••• | 23.0% | •••• | Delhi, India |
| Arahant Medcure Private Limited | ₹98.67 Cr (FY 2025) | •••• | •••• | 95.0% | •••• | New Delhi, Delhi, India |
| Visa Pharmaceuticals Private Limited | ₹98.08 Cr (FY 2016) | •••• | •••• | 34.0% | •••• | Kolkata, West Bengal, India |
| Inspira Bio-Pharm Private Limited | ₹97.29 Cr (FY 2025) | •••• | •••• | -17.0% | •••• | Mumbai, Maharashtra, India |
| Vea Impex (I) Private Limited | ₹96.93 Cr (FY 2025) | •••• | •••• | 16.0% | •••• | Mumbai, Maharashtra, India |
| Hospimax Healthcare Private Limited | ₹96.45 Cr (FY 2025) | •••• | •••• | 29.0% | •••• | New Delhi, Delhi, India |
Peers are the five companies nearest above and the five nearest below Antex Pharma by revenue in the Pharma industry (Pharma Retail and Distribution), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of Antex Pharma Private Limited
Antex Pharma Private Limited is audited by ANKIT SK JAIN & CO. for the financial year 2023.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| ANKIT SK JAIN & CO. | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of Antex Pharma Private Limited
Antex Pharma has 2 current directors and 6 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Rajesh Kumar Hariharprasad Tiwari | Director | 12 Dec 2019 | 6 Years 10 Months | Current |
| Amardeep Bansal Also directs: Acacia Pax LLP, Shell Agro Infrastructure Private Limited, Alexza Labs Private Limited and 1 more | Director | 06 Mar 2009 | 17 Years 7 Months | Current |
Ownership and Shareholding of Antex Pharma Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Antex Pharma Private Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 25 Oct 2025 | Hdfc Bank Limited | ₹8 Cr | Open |
| 18 Oct 2023 | Yes Bank Limited | ₹5 Cr | Open |
| 24 Oct 2020 | Hdfc Bank Limited | ₹50 Lakh | Open |
| 25 Nov 2024 | Uco Bank | ₹4.95 Cr | Satisfied |
| 02 Jul 2015 | Hdfc Bank Limited | ₹6 Cr | Satisfied |
Total charge records: 7 View all charges
Legal Cases of Antex Pharma Private Limited
Antex Pharma Private Limited has 223 court cases on record: 203 filed by Antex Pharma, 18 filed against it, 2 where it is another party. 116 cases are pending and 107 are disposed. Status as checked between 21 Sep 2026 and 04 Oct 2026.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 189 | 8 | 109 |
| High courts | 34 | 10 | 7 |
Cases on record (5 of 223)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, North, Delhi | Civil suit | Filed by the company against Yes Bank Limited | Pending |
| High Court of Delhi | Commercial suit | Filed by the company against Brown & Black Bio Private Limited | Pending |
| Madras High Court | Appeal | Filed against the company by Apex Laboratories Private Limited | Disposed |
| Madras High Court | Original application | Filed against the company by Apex Laboratories Private Limited | Disposed |
| District court, North West, Delhi | Civil suit | Filed against the company by Gnosis Pharmaceuticals Private Limited | Disposed |
Full case history
All 223 cases with case numbers, court, year-wise trend, opposite parties and decision dates are in the company report.
- Every case with its case number
- Year-wise trend
- Opposite parties
- Decision dates and orders
Verified entity values are shown only after access is granted.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
Associated Brands with Antex Pharma Private Limited
Antex Pharma operates one associated brand: Antex Pharma. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Marketing and distribution of pharmaceutical products and health supplements in India. | antexpharma.com |
Employees and EPFO Compliance at Antex Pharma Private Limited
Employment history and EPFO contributions of people linked to Antex Pharma.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Antex Pharma Private Limited
Antex Pharma Private Limited has 8 board changes on record since 2009: 2 appointments and 6 cessations. The latest: Rajesh Kumar Hariharprasad Tiwari ceased to be Additional Director on 09 May 2025.
13 earlier events are listed in the company report.
Credit Ratings, Litigation & Regulatory Alerts for Antex Pharma Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Antex Pharma Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Antex Pharma Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Antex Pharma Private Limited
Antex Pharma has 2 GST registrations: 1 active and 1 cancelled or inactive.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 06AAHCA8532F1ZS | Haryana | Active | 17 Jan 2019 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Antex Pharma Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Antex Pharma Private Limited
Antex Pharma is an active private limited company based in Delhi, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 06 March 2009 (17+ years old) and is registered under CIN U24100DL2009PTC188276.
Antex Pharma reported revenue of ₹98.92 Cr for FY 2024 (up 23% YoY).
Antex Pharma has 2 current directors:
- Rajesh Kumar Hariharprasad Tiwari - Director
- Amardeep Bansal - Director
Antex Pharma reported a net profit of ₹62.06 Lakh (net margin 0.6%) and EBITDA of ₹1.12 Cr (EBITDA margin 1.1%) for FY 2024, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Antex Pharma is 7% over three years and 1% over five years. In the latest year (FY 2024) revenue rose 23%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Antex Pharma is 06AAHCA8532F1ZS, registered in Haryana. The company has 2 GST registrations in all, of which 1 is active and 1 is cancelled or inactive.
The CIN (Corporate Identification Number) of Antex Pharma is U24100DL2009PTC188276. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Antex Pharma has 223 court cases on record: 203 filed by the company and 18 filed against it. 116 are pending. Most are in the district courts.
Antex Pharma was incorporated on 06 March 2009, making it 17+ years old. It is registered with the Registrar of Companies, Delhi.
The peers of Antex Pharma by revenue are Amtrax (India) Life Sciences Private Limited, Euro Lifecare Private Limited, Arham Drugs and Chemicals Private Limited, Jainam Pharma (India) Private Limited, LPH Pharma Private Limited and 5 more, all in the Pharma industry (Pharma Retail and Distribution).
Rajesh Kumar Hariharprasad Tiwari ceased to be Additional Director on 09 May 2025. Rajesh Kumar Hariharprasad Tiwari was appointed as Director on 12 Dec 2019. Sunny Mittal ceased to be Additional Director on 12 Dec 2019. Antex Pharma has 8 board changes on record in total.